Perigon Wealth Management’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.16M Buy
84,295
+59
+0.1% +$1.39K 0.03% 401
2026
Q1
$1.26M Buy
84,236
+1,355
+2% +$23.1K 0.02% 465
2025
Q4
$1.21M Sell
82,881
-33,600
-29% -$586K 0.02% 488
2025
Q3
$2.09M Sell
116,481
-1,093
-0.9% -$16K 0.04% 346
2025
Q2
$2.01M Buy
117,574
+14,644
+14% +$147K 0.05% 329
2025
Q1
$745K Sell
102,930
-62
-0.1% -$706 0.02% 520
2024
Q4
$1.51M Sell
102,992
-47,937
-32% -$708K 0.04% 352
2024
Q3
$1.79M Hold
150,929
0.05% 308
2024
Q2
$1.4M Sell
150,929
-43,322
-22% -$221K 0.04% 301
2024
Q1
$688K Buy
+194,251
New +$674K 0.02% 464

Other funds holding CORZ

Perigon Wealth Management's CORZ Position: Q2 2026 in Review

Perigon Wealth Management increased its Core Scientific (CORZ) stake by 0.07% in Q2 2026, buying an estimated $1.39K and bringing the position to 84,295 shares worth $2.16M. The position accounts for 0.03% of the portfolio, ranked #401.

Perigon Wealth Management first reported a position in CORZ in Q1 2024 and has held it in 10 quarters since. 413 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Perigon Wealth Management held 84,295 shares of Core Scientific worth $2.16M as of Q2 2026.
  • Perigon Wealth Management bought 59 Core Scientific shares in Q2 2026, an estimated $1.39K.
  • Core Scientific made up 0.03% of Perigon Wealth Management's portfolio in Q2 2026, its #401 holding.
  • Perigon Wealth Management first reported a position in Core Scientific in Q1 2024 and has held it in 10 quarters since.
  • 413 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Perigon Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.